✨
AI Summary
- Ritlecitinib shows promise for non-segmental vitiligo based on late-breaking data.
- Iltefat Hamzavi, MD, presented findings at the 2026 EADV Congress.
- Focus on new treatments for vitiligo and patient outcomes.